Osteogenic sarcoma presenting with lung metastasis

Oncologist

Volumn 7, Issue 2, 2002, Pages 144-153

  Staddon, Arthur P ^a   Lackman, Richard ^a   Robinson, Keith ^a   Shrager, Joseph B ^a   Warhol, Michael ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Chemotherapy; Osteogenic sarcoma; Surgery; Treatment

Indexed keywords

ADULT; ARTHRALGIA; ARTICLE; CANCER RESEARCH; CANCER STAGING; CASE REPORT; HUMAN; KNEE; LUNG METASTASIS; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEDICINE IN ART; OSTEOSARCOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036225090     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.7-2-144     Document Type: Article

References (30)

1. The angiographic response of osteosarcoma following pre-operative chemotherapy
2. The success of limb-salvage surgery in the adolescent patient with osteosarcoma
3. Limb salvage with osteoarticular allografts after resection of proximal tibia bone tumors
4. A modular endoprosthetic system for tumor and non-tumor reconstruction: Preliminary experience
5. Adenocarcinoma of kidney with metastasis to lung cured by lobectomy
6. Pulmonary resection for solitary metastatic sarcomas and carcinomas
7. Surgical treatment of metastatic tumors in the lungs
8. Surgical treatment and chemotherapy for pulmonary metastases from osteosarcoma
9. Metastasectomy for sarcomatous pediatric histologies: Results and prognostic factors
10. Reoperative pulmonary metastasectomy for sarcomatous pediatric histologies
11. Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: Results of a prospective trial
12. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity: Updated results of the Multi-Institutional Osteosarcoma Study
13. Sarcoma of bone
14. High-dose ifosfamide in bone and soft tissue sarcomas: Results of phase II and pilot studies-dose-response and schedule dependence
15. Premature ovarian failure after ifosfamide administration
16. Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy
17. A phase I trial of etoposide (VP) and escalating doses of ifosfamide (IFCS) plus G-CSF in recurrent pediatric sarcomas
18. Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology
19. Successful phase II trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A Pediatric Oncology Group trial (POG)
20. Phase II/III trial of etoposide and high-dose ifosamide in newly diagnosed metastatic osteosarcoma: A pediatric oncology group trial
21. Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma
22. Addition of ifosfamide and muramyl tripeptide to cisplatin, doxorubicin and high-dose methotrexate improves event-free survival (EFS) in localized osteosarcoma (OS)
23. ET-743 is an active drug in adult soft-tissue sarcoma (STS): A STBSG-EORTC phase II trial
24. Ecteinascidin-743 (ET-743) induces durable responses and promising 1-year survival rates in soft tissue sarcomas (STS): Final results of phase II and pharmacokinetic studies in the USA
25. Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI 571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs) expressing C-KITT (CD117)
26. STI 571, An active drug in metastatic gastric intestinal strand tumors (GIST), an EORTC phase I study
27. NCCN pediatric osteosarcoma practice guidelines